Medicina
Departamento
Asan Medical Center
Seúl, Corea del SurPublicaciones en colaboración con investigadores/as de Asan Medical Center (9)
2024
2023
-
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial
The Lancet, Vol. 401, Núm. 10378, pp. 733-746
2022
-
Optical coherence tomography in coronary atherosclerosis assessment and intervention
Nature Reviews Cardiology, Vol. 19, Núm. 10, pp. 684-703
2021
-
Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 4, pp. 273-284
2016
-
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): A phase 2B, open-label, randomised controlled trial
The Lancet Oncology, Vol. 17, Núm. 5, pp. 577-589
2014
-
Angiogenesis inhibitor therapies for advanced renal cell carcinoma: Toxicity and treatment patterns in clinical practice from a global medical chart review
International Journal of Oncology, Vol. 44, Núm. 1, pp. 5-16
2011
2008
2001
-
Long-term clinical outcomes after unprotected left main trunk percutaneous revascularization in 279 patients
Circulation, Vol. 104, Núm. 14, pp. 1609-1614